Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Rare diseases have become an attractive target for pharmaceutical companies both on the ASX and internationally.

Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a ...

Gepotidacin vs Nitrofurantoin in uUTI: Study Overview and Clinical Implications EP: 3 . Rethinking Uncomplicated UTI Treatment: Discussion of Aminoglycosides as an Alternative to Carbapenems ...

This article describes the clinical and economic impact of ischemic ... including management guidelines, unmet needs, and data surrounding asundexian and milvexian, 2 FXI inhibitors under ...

US FDA grants fast track designation to NKGen Biotech’s natural killer cell therapy, troculeucel to treat moderate Alzheimer’s disease: Santa Ana, California Saturday, Februar ...

Investigational treatments—therapies not yet approved for market introduction—provide a beacon of hope for tackling complex ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

Real-world evidence on genomic profiles and survival outcomes in patients with HER2-positive metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...